Elly Barry

Assessment of dexrazoxane as a cardioprotectant in doxorubicin-treated children with high-risk acute lymphoblastic leukaemia: long-term follow-up of a prospective, randomised, multicentre trial

Steven E. Lipshultz, Rebecca E. Scully, Stuart R. Lipsitz et al. · The Lancet Oncology · 2010 · 442 citations · Full text

Drug Safety, Hematological Malignancy, Oncology +9

Favorable Outcome for Adolescents With Acute Lymphoblastic Leukemia Treated on Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium Protocols

Elly Barry, Daniel J. DeAngelo, Donna Neuberg et al. · Journal of Clinical Oncology · 2007 · 191 citations

Phase 2 trial of clofarabine in combination with etoposide and cyclophosphamide in pediatric patients with refractory or relapsed acute lymphoblastic leukemia

Nobuko Hijiya, Blythe Thomson, Michael S. Isakoff et al. · Blood · 2011 · 122 citations · Full text

Absence of Secondary Malignant Neoplasms in Children With High-Risk Acute Lymphoblastic Leukemia Treated With Dexrazoxane

Elly Barry, Lynda M. Vrooman, Suzanne E. Dahlberg et al. · Journal of Clinical Oncology · 2008 · 118 citations · Full text

A multi-center phase I study of clofarabine, etoposide and cyclophosphamide in combination in pediatric patients with refractory or relapsed acute leukemia

Nobuko Hijiya, Paul S. Gaynon, Elly Barry et al. · Leukemia · 2009 · 85 citations

Hematological Malignancy, Pediatric Hematology, Medicine +8